Halozyme Therapeutics, Inc. (HALO)
68.51
-0.47
(-0.68%)
USD |
NASDAQ |
May 21, 16:00
68.52
+0.01
(+0.01%)
After-Hours: 19:59
Halozyme Therapeutics Price : 68.51 for May 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vertex Pharmaceuticals, Inc. | 433.48 |
| Agenus, Inc. | 3.175 |
| Inovio Pharmaceuticals, Inc. | 1.325 |
| Curis, Inc. | 0.49 |
| LadRx Corp. | 0.05 |
Price Related Metrics
| PE Ratio | 24.64 |
| PS Ratio | 5.530 |
| Price to Book Value | 37.00 |
| Price to Free Cash Flow | 12.49 |
| Earnings Yield | 4.06% |
| Market Cap | 8.126B |
| Operating PE Ratio | 9.708 |
| Normalized PE Ratio | 14.04 |